Subscribe to our newsletter and you will get all new informations directly from us.
CorFlow Therapeutics AG will present the first clinical results from the MOCA I trial during the upcoming Transcatheter Cardiovascular Therapeutics (TCT) conference [...]
CorFlow Therapeutics AG will today present the company during the 2019 Healthtech Summit in Lausanne, Switzerland.
CorFlow Therapeutics AG ("CorFlow") today announced that the company will present the Controlled Flow Infusion (CoFI™) technology for diagnosis and treatment of [...]
CorFlow Therapeutics AG today announced that the Swiss competent authority, Swissmedic, and the Swiss ethics committee, Swissethics, have approved the company's MOCA [...]
CorFlow Therapeutics AG today announced that the company will present further findings related to the diagnosis and treatment of coronary microvascular obstruction [...]
TCT18: CorFlow Presents Scientific Findings and is Selected as Finalist in the TCT Shark Tank Innovation Competitionadmin
CorFlow Therapeutics AG today announced that the company has been selected to present the CorFlow Controlled Flow Infusion (CoFI™) technology during the [...]
CorFlow Therapeutics AG today announced that leading interventional cardiologists from Europe, Japan and the United States have joined the CorFlow Scientific Advisory [...]
On March 2nd Medtech Insight, a leading publication covering the global medical device industry, featured CorFlow Therapeutics AG as one of the [...]
CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at the American College of Cardiology (ACC)admin
CorFlow Therapeutics AG today announced that the company will present fundamental new insights into the coronary microcirculation during the annual meeting of [...]
CorFlow Therapeutics AG today announced that Mrs. Esther Gerteis has been appointed CorFlow's VP Medical Affairs and will be a member of [...]
CorFlow Therapeutics AG today announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by [...]
CorFlow Therapeutics AG today announced that its ISO 13485:2016 compliant Quality Management System (QMS) has been certified by the British Standards Institution (BSI).
The MedTech Strategist has published a review article in it's current issue of CorFlow Therapeutics AG and CorFlow's Controlled Flow Infusion (CoFITM) [...]
ReFlow Therapeutics AG ("ReFlow") today announced that the Company has been awarded a Swiss non-dilutive public grant from the Swiss Commission for [...]
ReFlow Therapeutics AG ("ReFlow") today announced that the Company closed it's oversubscribed seed financing round raising an undisclosed single digit million Swiss Francs amount. ReFlow is [...]